(0.12%) 5 303.27 points
(0.34%) 40 004 points
(-0.07%) 16 686 points
(-0.27%) $79.84
(0.42%) $2.64
(0.22%) $2 422.60
(1.20%) $31.64
(0.56%) $1 096.10
(-0.02%) $0.920
(0.00%) $10.68
(-0.02%) $0.787
(0.09%) $91.05
1.63% $ 110.23
Live Chart Being Loaded With Signals
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics...
Stats | |
---|---|
Volumen de hoy | 1.03M |
Volumen promedio | 846 530 |
Capitalización de mercado | 13.60B |
EPS | $0 ( 2024-05-09 ) |
Próxima fecha de ganancias | ( $1.150 ) 2024-08-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 74.99 |
ATR14 | $0.0600 (0.05%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-05-01 | Vandebroek Sophie V. | Buy | 1 218 | Common Stock |
2024-05-01 | Vandebroek Sophie V. | Buy | 977 | Common Stock |
2024-05-01 | Barrett Peter | Buy | 1 218 | Common Stock |
2024-05-01 | Barrett Peter | Buy | 977 | Common Stock |
2024-05-01 | Witz Pascale | Buy | 1 218 | Common Stock |
INSIDER POWER |
---|
44.21 |
Last 69 transactions |
Buy: 359 333 | Sell: 139 224 |
Volumen Correlación
Revvity, Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Revvity, Inc. Correlación - Moneda/Commodity
Revvity, Inc. Finanzas
Annual | 2023 |
Ingresos: | $2.75B |
Beneficio Bruto: | $1.17B (42.70 %) |
EPS: | $1.440 |
FY | 2023 |
Ingresos: | $2.75B |
Beneficio Bruto: | $1.17B (42.70 %) |
EPS: | $1.440 |
FY | 2022 |
Ingresos: | $3.31B |
Beneficio Bruto: | $1.99B (60.08 %) |
EPS: | $4.51 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Revvity, Inc.
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico